(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1321712 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGEF3 mRNA CTD PMID:22079256 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of ARHGEF3 mRNA CTD PMID:32145629 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ARHGEF3 mRNA CTD PMID:35192832 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1321713 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1321713 6480464 Tetrachlorodibenzodioxin results in increased expression of ARHGEF3 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARHGEF3 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1321713 6480464 Tetrachlorodibenzodioxin affects the expression of ARHGEF3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARHGEF3 mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ARHGEF3 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ARHGEF3 mRNA CTD PMID:21346803 4,4'-sulfonyldiphenol increases expression ISO RGD:1321713 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ARHGEF3 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ARHGEF3 mRNA CTD PMID:36041667 4-hydroxynon-2-enal decreases expression ISO RGD:1321713 6480464 4-hydroxy-2-nonenal results in decreased expression of ARHGEF3 mRNA CTD PMID:19191707 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ARHGEF3 mRNA CTD PMID:24780913 aflatoxin B1 affects expression ISO RGD:1321712 6480464 Aflatoxin B1 affects the expression of ARHGEF3 protein CTD PMID:20106945 Aflatoxin B2 alpha increases methylation ISO RGD:1321712 6480464 aflatoxin B2 results in increased methylation of ARHGEF3 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1321712 6480464 Tretinoin results in increased expression of ARHGEF3 mRNA CTD PMID:21934132 , PMID:33167477 antirheumatic drug decreases expression ISO RGD:1321712 6480464 Antirheumatic Agents results in decreased expression of ARHGEF3 mRNA CTD PMID:24449571 benzo[a]pyrene increases expression ISO RGD:1321712 6480464 Benzo(a)pyrene results in increased expression of ARHGEF3 mRNA CTD PMID:20106945 benzo[a]pyrene decreases methylation ISO RGD:1321712 6480464 Benzo(a)pyrene results in decreased methylation of ARHGEF3 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1321712 6480464 Benzo(a)pyrene affects the methylation of ARHGEF3 5' UTR, Benzo(a)pyrene affects the methylation of ARHGEF3 intron CTD PMID:27901495 , PMID:30157460 benzo[b]fluoranthene increases expression ISO RGD:1321713 6480464 benzo(b)fluoranthene results in increased expression of ARHGEF3 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:1321712 6480464 benzo(e)pyrene results in increased methylation of ARHGEF3 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide increases expression ISO RGD:1321712 6480464 Mustard Gas results in increased expression of ARHGEF3 mRNA CTD PMID:25102026 bisphenol A decreases expression ISO RGD:1321713 6480464 bisphenol A results in decreased expression of ARHGEF3 mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ARHGEF3 mRNA CTD PMID:35192832 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ARHGEF3 mRNA CTD PMID:36041667 bisphenol A increases methylation ISO RGD:1321712 6480464 bisphenol A results in increased methylation of ARHGEF3 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1321712 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ARHGEF3 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ARHGEF3 mRNA CTD PMID:32145629 bisphenol A increases expression ISO RGD:1321712 6480464 bisphenol A results in increased expression of ARHGEF3 mRNA CTD PMID:27685785 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARHGEF3 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1321713 6480464 bisphenol F results in increased expression of ARHGEF3 mRNA CTD PMID:30951980 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ARHGEF3 mRNA CTD PMID:36041667 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ARHGEF3 promoter CTD PMID:22457795 calcitriol decreases expression ISO RGD:1321712 6480464 Calcitriol results in decreased expression of ARHGEF3 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:1321712 6480464 Carbamazepine affects the expression of ARHGEF3 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:1321713 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone affects response to substance ISO RGD:1321712 6480464 ARHGEF3 gene SNP affects the susceptibility to Chlordecone CTD PMID:25622337 chlorpyrifos increases expression ISO RGD:1321713 6480464 Chlorpyrifos results in increased expression of ARHGEF3 mRNA CTD PMID:32715474 cisplatin multiple interactions ISO RGD:1321713 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ARHGEF3 mRNA CTD PMID:23625948 clofibrate multiple interactions ISO RGD:1321713 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:1321713 6480464 Clofibrate results in increased expression of ARHGEF3 mRNA CTD PMID:23811191 copper atom increases expression EXP 6480464 Copper results in increased expression of ARHGEF3 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of ARHGEF3 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1321712 6480464 Copper Sulfate results in decreased expression of ARHGEF3 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1321713 6480464 Asbestos, Crocidolite results in decreased expression of ARHGEF3 mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ARHGEF3 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1321712 6480464 Cyclosporine results in increased expression of ARHGEF3 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1321712 6480464 Cyclosporine results in decreased expression of ARHGEF3 mRNA CTD PMID:25562108 , PMID:27989131 cytarabine decreases expression ISO RGD:1321712 6480464 Cytarabine results in decreased expression of ARHGEF3 mRNA CTD PMID:21198554 dibutyl phthalate increases expression ISO RGD:1321713 6480464 Dibutyl Phthalate results in increased expression of ARHGEF3 mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:1321712 6480464 Diclofenac affects the expression of ARHGEF3 mRNA CTD PMID:24752500 diclofenac decreases expression ISO RGD:1321713 6480464 Diclofenac results in decreased expression of ARHGEF3 mRNA CTD PMID:35537566 dorsomorphin multiple interactions ISO RGD:1321712 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1321712 6480464 Doxorubicin results in decreased expression of ARHGEF3 mRNA CTD PMID:29803840 entinostat multiple interactions ISO RGD:1321712 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1321712 6480464 entinostat results in increased expression of ARHGEF3 mRNA CTD PMID:26272509 ethanol affects splicing ISO RGD:1321713 6480464 Ethanol affects the splicing of ARHGEF3 mRNA CTD PMID:30319688 fenthion decreases expression ISO RGD:1321713 6480464 Fenthion results in decreased expression of ARHGEF3 mRNA CTD PMID:34813904 fluvastatin multiple interactions ISO RGD:1321712 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA CTD PMID:16996129 formaldehyde decreases expression ISO RGD:1321712 6480464 Formaldehyde results in decreased expression of ARHGEF3 mRNA CTD PMID:20655997 fulvestrant multiple interactions ISO RGD:1321712 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ARHGEF3 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ARHGEF3 mRNA CTD PMID:22061828 , PMID:33387578 lead(0) affects expression ISO RGD:1321712 6480464 Lead affects the expression of ARHGEF3 mRNA CTD PMID:28903495 lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of ARHGEF3 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO RGD:1321712 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide decreases expression ISO RGD:1321712 6480464 Lipopolysaccharides results in decreased expression of ARHGEF3 mRNA CTD PMID:35811015 methapyrilene increases methylation ISO RGD:1321712 6480464 Methapyrilene results in increased methylation of ARHGEF3 intron CTD PMID:30157460 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ARHGEF3 gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO RGD:1321712 6480464 Methyl Methanesulfonate results in decreased expression of ARHGEF3 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1321712 6480464 methylmercuric chloride results in increased expression of ARHGEF3 mRNA CTD PMID:28001369 nickel atom decreases expression ISO RGD:1321712 6480464 Nickel results in decreased expression of ARHGEF3 mRNA CTD PMID:23195993 ozone multiple interactions ISO RGD:1321713 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARHGEF3 mRNA CTD PMID:34911549 ozone decreases expression EXP 6480464 Ozone results in decreased expression of ARHGEF3 mRNA CTD PMID:35737395 paracetamol multiple interactions ISO RGD:1321713 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ARHGEF3 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ARHGEF3 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1321712 6480464 Acetaminophen results in increased expression of ARHGEF3 mRNA CTD PMID:22230336 phenobarbital affects expression ISO RGD:1321713 6480464 Phenobarbital affects the expression of ARHGEF3 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1321712 6480464 Phenylmercuric Acetate results in increased expression of ARHGEF3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1321712 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of ARHGEF3 mRNA CTD PMID:15215175 pirinixic acid increases expression ISO RGD:1321713 6480464 pirinixic acid results in increased expression of ARHGEF3 mRNA CTD PMID:18301758 , PMID:23811191 potassium chromate multiple interactions ISO RGD:1321712 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGEF3 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1321712 6480464 potassium chromate(VI) results in decreased expression of ARHGEF3 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1321713 6480464 Pregnenolone Carbonitrile results in increased expression of ARHGEF3 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:1321712 6480464 Progesterone results in increased expression of ARHGEF3 mRNA CTD PMID:18070364 quercetin decreases expression ISO RGD:1321712 6480464 Quercetin results in decreased expression of ARHGEF3 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1321712 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ARHGEF3 mRNA CTD PMID:23557933 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1321712 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1321712 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1321713 6480464 Silicon Dioxide results in decreased expression of ARHGEF3 mRNA CTD PMID:19073995 silver atom decreases expression ISO RGD:1321712 6480464 Silver results in decreased expression of ARHGEF3 mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:1321712 6480464 Silver results in decreased expression of ARHGEF3 mRNA CTD PMID:26014281 sodium arsenite affects methylation ISO RGD:1321712 6480464 sodium arsenite affects the methylation of ARHGEF3 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:1321713 6480464 sodium arsenite results in increased expression of ARHGEF3 mRNA CTD PMID:36209798 sunitinib decreases expression ISO RGD:1321712 6480464 Sunitinib results in decreased expression of ARHGEF3 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1321713 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO RGD:1321713 6480464 Testosterone deficiency results in increased expression of ARHGEF3 mRNA CTD PMID:33848595 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ARHGEF3 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ARHGEF3 mRNA CTD PMID:23411599 , PMID:34492290 trichloroethene increases expression ISO RGD:1321713 6480464 Trichloroethylene results in increased expression of ARHGEF3 mRNA CTD PMID:25549359 trichostatin A increases expression ISO RGD:1321712 6480464 trichostatin A results in increased expression of ARHGEF3 mRNA CTD PMID:24935251 more ... trichostatin A multiple interactions ISO RGD:1321712 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:1321712 6480464 Triclosan results in increased expression of ARHGEF3 mRNA CTD PMID:30510588 trovafloxacin decreases expression ISO RGD:1321713 6480464 trovafloxacin results in decreased expression of ARHGEF3 mRNA CTD PMID:35537566 tungsten decreases expression ISO RGD:1321713 6480464 Tungsten results in decreased expression of ARHGEF3 mRNA CTD PMID:30912803 valproic acid increases expression ISO RGD:1321712 6480464 Valproic Acid results in increased expression of ARHGEF3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1321712 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:1321712 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGEF3 mRNA CTD PMID:27188386 zinc sulfate decreases expression ISO RGD:1321712 6480464 Zinc Sulfate results in decreased expression of ARHGEF3 mRNA CTD PMID:12756304 zoledronic acid multiple interactions ISO RGD:1321712 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA CTD PMID:16996129